These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

872 related articles for article (PubMed ID: 33786465)

  • 1. Defining long COVID: Going back to the start.
    Alwan NA; Johnson L
    Med; 2021 May; 2(5):501-504. PubMed ID: 33786465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
    Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ
    Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long COVID in people living with HIV.
    Peluso MJ; Antar AAR
    Curr Opin HIV AIDS; 2023 May; 18(3):126-134. PubMed ID: 37144614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-COVID-19 syndrome/condition or long COVID: Persistent illness after acute SARS CoV-2 infection.
    Allard N; Miller A; Morgan M; Chakraborty S
    Aust J Gen Pract; 2022 Dec; 51(12):952-957. PubMed ID: 36451331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.
    Ryan FJ; Hope CM; Masavuli MG; Lynn MA; Mekonnen ZA; Yeow AEL; Garcia-Valtanen P; Al-Delfi Z; Gummow J; Ferguson C; O'Connor S; Reddi BAJ; Hissaria P; Shaw D; Kok-Lim C; Gleadle JM; Beard MR; Barry SC; Grubor-Bauk B; Lynn DJ
    BMC Med; 2022 Jan; 20(1):26. PubMed ID: 35027067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical case definition of post-COVID-19 condition by a Delphi consensus.
    Soriano JB; Murthy S; Marshall JC; Relan P; Diaz JV;
    Lancet Infect Dis; 2022 Apr; 22(4):e102-e107. PubMed ID: 34951953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Common is Long COVID in Children and Adolescents?
    Zimmermann P; Pittet LF; Curtis N
    Pediatr Infect Dis J; 2021 Dec; 40(12):e482-e487. PubMed ID: 34870392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
    Sukocheva OA; Maksoud R; Beeraka NM; Madhunapantula SV; Sinelnikov M; Nikolenko VN; Neganova ME; Klochkov SG; Amjad Kamal M; Staines DR; Marshall-Gradisnik S
    J Adv Res; 2022 Sep; 40():179-196. PubMed ID: 36100326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Long COVID': Making The Invisible Visible.
    Bovo MV
    Health Aff (Millwood); 2021 Sep; 40(9):1510-1513. PubMed ID: 34495729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients.
    Peghin M; De Martino M; Palese A; Gerussi V; Bontempo G; Graziano E; Visintini E; D'Elia D; Dellai F; Marrella F; Fabris M; Curcio F; Sartor A; Isola M; Tascini C
    Clin Microbiol Infect; 2022 Aug; 28(8):1140-1148. PubMed ID: 35339673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol.
    Kuut TA; Müller F; Aldenkamp A; Assmann-Schuilwerve E; Braamse A; Geerlings SE; Gibney KB; Kanaan RAA; Nieuwkerk P; Olde Hartman TC; Pauëlsen D; Prins M; Slieker K; Van Vugt M; Bleeker-Rovers CP; Keijmel SP; Knoop H
    Trials; 2021 Dec; 22(1):867. PubMed ID: 34857010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female gender is associated with long COVID syndrome: a prospective cohort study.
    Bai F; Tomasoni D; Falcinella C; Barbanotti D; Castoldi R; Mulè G; Augello M; Mondatore D; Allegrini M; Cona A; Tesoro D; Tagliaferri G; Viganò O; Suardi E; Tincati C; Beringheli T; Varisco B; Battistini CL; Piscopo K; Vegni E; Tavelli A; Terzoni S; Marchetti G; Monforte AD
    Clin Microbiol Infect; 2022 Apr; 28(4):611.e9-611.e16. PubMed ID: 34763058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-acute COVID-19 outcomes in children requiring hospitalisation.
    Bossley CJ; Kavaliunaite E; Harman K; Cook J; Ruiz G; Gupta A
    Sci Rep; 2022 May; 12(1):8208. PubMed ID: 35581348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID.
    Goh D; Lim JCT; Fernaíndez SB; Joseph CR; Edwards SG; Neo ZW; Lee JN; Caballero SG; Lau MC; Yeong JPS
    Front Immunol; 2022; 13():939989. PubMed ID: 36131932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study.
    Haddad A; Janda A; Renk H; Stich M; Frieh P; Kaier K; Lohrmann F; Nieters A; Willems A; Huzly D; Dulovic A; Schneiderhan-Marra N; Jacobsen EM; Fabricius D; Zernickel M; Stamminger T; Bode SFN; Himpel T; Remppis J; Engel C; Peter A; Ganzenmueller T; Hoffmann GF; Haase B; Kräusslich HG; Müller B; Franz AR; Debatin KM; Tönshoff B; Henneke P; Elling R
    EBioMedicine; 2022 Oct; 84():104245. PubMed ID: 36155957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring the development of post-COVID–19 syndrome].
    Tamasi J; Kalabay L
    Orv Hetil; 2022 Feb; 163(9):335-342. PubMed ID: 35220274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long COVID: An overview.
    Raveendran AV; Jayadevan R; Sashidharan S
    Diabetes Metab Syndr; 2021; 15(3):869-875. PubMed ID: 33892403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
    Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
    Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.